JP2009225711A - 組換え微生物 - Google Patents
組換え微生物 Download PDFInfo
- Publication number
- JP2009225711A JP2009225711A JP2008074252A JP2008074252A JP2009225711A JP 2009225711 A JP2009225711 A JP 2009225711A JP 2008074252 A JP2008074252 A JP 2008074252A JP 2008074252 A JP2008074252 A JP 2008074252A JP 2009225711 A JP2009225711 A JP 2009225711A
- Authority
- JP
- Japan
- Prior art keywords
- gene
- polypeptide
- recombinant microorganism
- base sequence
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 58
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 142
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 40
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 38
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 38
- 229920001184 polypeptide Polymers 0.000 claims abstract description 37
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 17
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 17
- 101100507383 Bacillus subtilis (strain 168) yvyD gene Proteins 0.000 claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 claims abstract description 17
- 239000012634 fragment Substances 0.000 claims description 46
- 238000011144 upstream manufacturing Methods 0.000 claims description 18
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 14
- 108010059892 Cellulase Proteins 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 11
- 230000005026 transcription initiation Effects 0.000 claims description 8
- 230000014621 translational initiation Effects 0.000 claims description 8
- 230000028327 secretion Effects 0.000 claims description 7
- 230000003248 secreting effect Effects 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
- 230000006798 recombination Effects 0.000 claims description 3
- 238000005215 recombination Methods 0.000 claims description 2
- 241000894007 species Species 0.000 abstract 1
- 238000000034 method Methods 0.000 description 28
- 108020004414 DNA Proteins 0.000 description 23
- 238000012217 deletion Methods 0.000 description 14
- 230000037430 deletion Effects 0.000 description 14
- 206010059866 Drug resistance Diseases 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 239000003550 marker Substances 0.000 description 9
- 125000003275 alpha amino acid group Chemical group 0.000 description 8
- 238000012224 gene deletion Methods 0.000 description 7
- 230000002779 inactivation Effects 0.000 description 7
- 101710166469 Endoglucanase Proteins 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 229940106157 cellulase Drugs 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 101150037061 yvyD gene Proteins 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 102000013142 Amylases Human genes 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000276408 Bacillus subtilis subsp. subtilis str. 168 Species 0.000 description 4
- 235000019418 amylase Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 238000009776 industrial production Methods 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 229960000268 spectinomycin Drugs 0.000 description 4
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 4
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 229940024171 alpha-amylase Drugs 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108010084185 Cellulases Proteins 0.000 description 2
- 102000005575 Cellulases Human genes 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 239000003262 industrial enzyme Substances 0.000 description 2
- 230000010365 information processing Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- BETIRLUWOMCBBJ-UHFFFAOYSA-N 2-[6-[4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC=3C=CC(=CC=3)[N+]([O-])=O)C(O)C2O)CO)C(O)C1O BETIRLUWOMCBBJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001037822 Bacillus bacterium Species 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- -1 mong Species 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
【解決手段】枯草菌遺伝子yvyD又は当該遺伝子に相当する遺伝子が欠失又は不活性化された微生物株に、異種のタンパク質又はポリペプチドをコードする遺伝子を導入した組換え微生物。
【選択図】なし
Description
Nature,390,249,1997 Science,277,1453,1997
枯草菌168株から抽出したゲノムDNAを鋳型とし、表1に示したyvyD FW1とyvyD/Sp R、及びyvyD/Sp FとyvyD RVの各プライマーセットを用いて、ゲノム上のyvyD遺伝子の上流に隣接する1.0kbp断片(A)、及び下流に隣接する1.0kbp断片(B)をそれぞれ調製した。また、スペクチノマイシン耐性遺伝子を有するプラスミドpDG1727[Gene, 167, 335, (1995)]を鋳型とし、表1に示したSp F及びSp Rのプライマーセットを用いて、スペクチノマイシン耐性遺伝子領域(C)を調製した。次に、得られた(A)(B)(C)3断片を混合して鋳型とし、yvyD FW2とyvyD RV2のプライマーを用いてPCRを行ない、3断片を(A)-(C)-(B)の順になる様に結合させ、遺伝子欠失用のDNA断片を得た(図1参照)。このDNA断片を用いて、コンピテント法により枯草菌168株の形質転換を行い、スペクチノマイシン(0.5μg/mL)を含むLB寒天培地上に生育したコロニーを形質転換体として分離した。さらに得られた形質転換体からゲノムDNAを抽出し、これを鋳型とするPCRによってyvyD遺伝子がスペクチノマイシン耐性遺伝子と置換され、結果として目的とする遺伝子欠失株となっていることを確認した。以上のようにしてyvyD欠失株(168ΔyvyD)を作製した。
実施例1にて得られた168ΔyvyD株、及び対照として枯草菌168株に、Bacillus属細菌 KSM-S237株(FERM BP-7875)由来のアルカリセルラーゼ遺伝子(特開2000-210081号公報)をコードするDNA断片(3.1kb)が、シャトルベクターpHY300PLKのBamHI制限酵素切断点に挿入された組換えプラスミドpHY-S237をプロトプラスト形質転換法によって導入した。これによって得られた菌株を5mLのLB培地で30℃で15時間振盪培養を行い、更にこの培養液0.6mLを30mLの2xL−マルトース培地(2%トリプトン、1%酵母エキス、1%塩化ナトリウム、7.5%マルトース、7.5ppm硫酸マンガン4-5水和物、15ppmテトラサイクリン)に接種し、30℃で3日間、振盪培養を行った(この際、測定誤差を算出する目的で培養を3回行っている)。培養後、遠心分離によって菌体を除いた培養液上清のアルカリセルラーゼ活性を測定し、菌体外に分泌生産されたアルカリセルラーゼの量を求めた。セルラーゼ活性測定については、1/7.5M リン酸緩衝液(pH7.4 和光純薬)で適宜希釈したサンプル溶液50μLに0.4mM p-nitrophenyl-β-D-cellotrioside(生化学工業)を50μL加えて混和し、30℃にて反応を行った際に遊離するp-ニトロフェノール量を420nmにおける吸光度(OD420nm)変化により定量した。1分間に1μmolのp-ニトロフェノールを遊離させる酵素量を1Uとし、生産性比較は、野生株である枯草菌168株の生産性を100%とする相対値により比較した(表2)。この結果、宿主として168ΔyvyD株を用いた場合、対照の168株(野生型)の場合と比較して高いアルカリセルラーゼの分泌生産が認められた。
Claims (8)
- 枯草菌遺伝子yvyD又は当該遺伝子に相当する遺伝子が欠失又は不活性化された微生物株に、異種のタンパク質又はポリペプチドをコードする遺伝子を導入した組換え微生物。
- 枯草菌遺伝子yvyDに相当する遺伝子が、配列番号1に示す塩基配列と80%以上の同一性を有する塩基配列からなる遺伝子である請求項1記載の組み換え微生物。
- 微生物が枯草菌又はその他のバチルス属細菌である請求項1又は2記載の組換え微生物。
- 異種のタンパク質又はポリペプチドをコードする遺伝子の上流に転写開始制御領域、翻訳開始制御領域及び分泌シグナル領域から選ばれる1以上の領域を結合した請求項1〜3のいずれか1項記載の組換え微生物。
- 転写開始制御領域、翻訳開始制御領域及び分泌シグナル領域からなる3領域を結合したものである請求項4記載の組換え微生物。
- 分泌シグナル領域がバチルス属細菌のセルラーゼ遺伝子由来のものであり、転写開始制御領域及び翻訳開始制御領域が当該セルラーゼ遺伝子の上流0.6〜1kb領域由来のものである請求項4又は5記載の組換え微生物。
- 転写開始制御領域、翻訳開始制御領域及び分泌シグナル領域からなる3領域が、配列番号2で示される塩基配列からなるセルラーゼ遺伝子の塩基番号1〜659の塩基配列又は当該塩基配列のいずれかと70%以上の同一性を有する塩基配列からなるDNA断片、又は当該塩基配列の一部が欠失した塩基配列からなるDNA断片である請求項5記載の組換え微生物。
- 請求項1〜7のいずれか1項記載の組換え微生物を用いるタンパク質又はポリペプチドの製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008074252A JP5294666B2 (ja) | 2008-03-21 | 2008-03-21 | 組換え微生物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008074252A JP5294666B2 (ja) | 2008-03-21 | 2008-03-21 | 組換え微生物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009225711A true JP2009225711A (ja) | 2009-10-08 |
JP5294666B2 JP5294666B2 (ja) | 2013-09-18 |
Family
ID=41241877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008074252A Active JP5294666B2 (ja) | 2008-03-21 | 2008-03-21 | 組換え微生物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5294666B2 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012135214A (ja) * | 2010-12-24 | 2012-07-19 | Kao Corp | 組換え微生物を用いたタンパク質の製造方法 |
JP2013017408A (ja) * | 2011-07-08 | 2013-01-31 | National Research Inst Of Brewing | 微生物のコウジ酸生産性を向上させる方法 |
JP2014158429A (ja) * | 2013-02-19 | 2014-09-04 | Kao Corp | ポリ−ガンマ−グルタミン酸の生産方法 |
JP2014158430A (ja) * | 2013-02-19 | 2014-09-04 | Kao Corp | セルラーゼの生産方法 |
JP2014158428A (ja) * | 2013-02-19 | 2014-09-04 | Kao Corp | アルカリプロテアーゼの生産方法 |
WO2023137264A1 (en) | 2022-01-13 | 2023-07-20 | Danisco Us Inc. | Compositions and methods for enhanced protein production in gram‑positive bacterial cells |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007130013A (ja) * | 2005-10-13 | 2007-05-31 | Kao Corp | 新規枯草菌変異株 |
-
2008
- 2008-03-21 JP JP2008074252A patent/JP5294666B2/ja active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007130013A (ja) * | 2005-10-13 | 2007-05-31 | Kao Corp | 新規枯草菌変異株 |
Non-Patent Citations (4)
Title |
---|
JPN6013009799; J Bacteriol., 1998年, 第180巻, 6674-6680ページ * |
JPN6013009801; Proc Natl Acad Sci USA., 1991年, 第88巻, 9092-9096ページ * |
JPN6013009803; J Mol Biol., 1992年, 第226巻, 85-99ページ * |
JPN6013009805; Nature, 1997年, 第390巻, 249-256ページ * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012135214A (ja) * | 2010-12-24 | 2012-07-19 | Kao Corp | 組換え微生物を用いたタンパク質の製造方法 |
JP2013017408A (ja) * | 2011-07-08 | 2013-01-31 | National Research Inst Of Brewing | 微生物のコウジ酸生産性を向上させる方法 |
JP2014158429A (ja) * | 2013-02-19 | 2014-09-04 | Kao Corp | ポリ−ガンマ−グルタミン酸の生産方法 |
JP2014158430A (ja) * | 2013-02-19 | 2014-09-04 | Kao Corp | セルラーゼの生産方法 |
JP2014158428A (ja) * | 2013-02-19 | 2014-09-04 | Kao Corp | アルカリプロテアーゼの生産方法 |
WO2023137264A1 (en) | 2022-01-13 | 2023-07-20 | Danisco Us Inc. | Compositions and methods for enhanced protein production in gram‑positive bacterial cells |
Also Published As
Publication number | Publication date |
---|---|
JP5294666B2 (ja) | 2013-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006296268A (ja) | 組換え微生物 | |
JP4336184B2 (ja) | 組換え微生物 | |
JP5294666B2 (ja) | 組換え微生物 | |
JP4336082B2 (ja) | 宿主微生物 | |
JP2005137308A (ja) | 組換え微生物 | |
JP4915728B2 (ja) | 組換え微生物 | |
JP5513759B2 (ja) | タンパク質又はポリペプチドの生産方法 | |
JP4388272B2 (ja) | 宿主微生物 | |
JP4839144B2 (ja) | 宿主微生物 | |
JP4832153B2 (ja) | 組換え微生物 | |
JP4509743B2 (ja) | 組換え微生物 | |
JP4496000B2 (ja) | 宿主微生物 | |
JP2006345860A (ja) | 組換えバチルス属細菌 | |
JP4643999B2 (ja) | 組換え微生物 | |
JP4676848B2 (ja) | 組換え微生物 | |
JP4676847B2 (ja) | 組換え微生物 | |
JP5140313B2 (ja) | 組換え微生物 | |
WO2005045045A2 (en) | Recombinant microorganism | |
JP4839169B2 (ja) | 組換え微生物 | |
JP4861659B2 (ja) | 組換え微生物 | |
JP5829802B2 (ja) | 組換え枯草菌 | |
JP2009034067A (ja) | 組換え微生物 | |
JP2009038985A (ja) | 微生物及びこれを用いたタンパク質又ポリペプチドの製造方法 | |
JP4463871B2 (ja) | 組換え微生物 | |
JP5474448B2 (ja) | 変異バチルス属細菌 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101203 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130305 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130507 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130604 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130611 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5294666 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |